Pharmacogenetic Testing, Informed Consent and the Problem of Secondary Information

Abstract excerpt

Numerous benefits for patients have been predicted if prescribing decisions were routinely accompanied by pharmacogenetic testing. So far, little attention has been paid to the possibility that the routine application of this new technology could result in considerable harm to patients. This article emphasises that pharmacogenetic testing shares both the opportunities and the pitfalls with 'conventional'...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ethics in Clinical Research
• Share to Pharmacogenetics and Drug Metabolism
• Share to Race, Genetics, and Society